CLINICAL TRIALS PROFILE FOR AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

All Clinical Trials for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00136851 ↗	Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension	Completed	Novartis Pharmaceuticals	Phase 4	2004-12-01	This trial is designed to study the efficacy of an amlodipine besylate/benazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension.
NCT01155895 ↗	Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions	Completed	Dr. Reddy's Laboratories Limited	Phase 1	2004-03-01	The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Lotrel®) 10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules, under fasting conditions.
NCT01155908 ↗	Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions	Completed	Dr. Reddy's Laboratories Limited	Phase 1	2005-04-01	The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Lotrel®) 10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules, under non-fasting (fed) conditions.
NCT01505998 ↗	Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions	Completed	Dr. Reddy's Laboratories Limited	Phase 1	2007-03-01	The purpose of this study single dose bioequivalence of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg capsules with Lotrel® capsules in healthy human subjects and monitor clinical status, adverse events and laboratory investigations and assess relative safety and tolerance under fed conditions.
NCT01506011 ↗	Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions	Completed	Dr. Reddy's Laboratories Limited	Phase 1	2007-03-01	The purpose of this study single dose bioequivalence of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg capsules with Lotrel® capsules in healthy human subjects and monitor clinical status, adverse events and laboratory investigations and assess relative safety and tolerance under fasting conditions

Clinical Trial Conditions for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Condition Name

Condition Name for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Intervention	Trials
Healthy	2
Hypertension	2
Fasting	1
Fed	1

Condition MeSH

Condition MeSH for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Intervention	Trials
Hypertension	2
Malnutrition	1

Clinical Trial Locations for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Trials by Country

Trials by Country for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Location	Trials
India	2
United States	1
China	1

Trials by US State

Trials by US State for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Location	Trials
New Jersey	1

Clinical Trial Progress for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 4	2
Phase 1	4

Clinical Trial Status

Clinical Trial Status for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	5
Active, not recruiting	1

Clinical Trial Sponsors for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Sponsor Name

Sponsor Name for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Sponsor	Trials
Dr. Reddy's Laboratories Limited	4
Shanghai Jiao Tong University School of Medicine	1
Novartis Pharmaceuticals	1

Sponsor Type

Sponsor Type for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Sponsor	Trials
Industry	5
Other	1